Literature DB >> 8449925

Purification and characterization of the prohormone convertase PC1(PC3).

Y Zhou1, I Lindberg.   

Abstract

The prohormone convertases PC1 (also known as PC3) and PC2 have been implicated in the biosynthesis of several polypeptide hormones and neuropeptides. In order to understand the regulation and the cell biology of prohormone cleavage, we have purified recombinant mouse PC1 from the conditioned medium of overexpressing Chinese hamster ovary cells. Recombinant PC1 was found to be an 87-kDa calcium-dependent proteinase with an inhibitor profile similar to that of Kex2 and furin. However, unlike furin, the optimum pH for PC1 activity is between pH 5.5 and 6.5. Like furin, the enzyme is activated at millimolar rather than at micromolar concentrations of calcium. Chinese hamster ovary/PC1 cells secrete the mature form of PC1, converted by a proteolytic cleavage on the carboxyl side of the RSKR motif located at residues 80-83. This conversion occurs very early in biosynthesis, suggesting that, like Kex2 and furin, PC1 may be activated autocatalytically. Specificity studies with fluorogenic substrates showed that the enzyme prefers substrates with an arginine 4 amino acids amino-terminal to the cleavage site; synthetic tripeptide substrates containing only pairs of basic amino acids are not well cleaved. However, the neuropeptide precursor proenkephalin is cleaved by PC1 to yield a peptide B-sized peptide; since peptide B represents the naturally occurring carboxyl-terminal fragment of proenkephalin, these data suggest a role for PC1 in the processing of this precursor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8449925

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Measurement of secretory vesicle pH reveals intravesicular alkalinization by vesicular monoamine transporter type 2 resulting in inhibition of prohormone cleavage.

Authors:  C G Blackmore; A Varro; R Dimaline; L Bishop; D V Gallacher; G J Dockray
Journal:  J Physiol       Date:  2001-03-15       Impact factor: 5.182

2.  Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing.

Authors:  L D Fricker; A A McKinzie; J Sun; E Curran; Y Qian; L Yan; S D Patterson; P L Courchesne; B Richards; N Levin; N Mzhavia; L A Devi; J Douglass
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

3.  The transmembrane domain of the prohormone convertase PC3: a key motif for targeting to the regulated secretory pathway.

Authors:  Hong Lou; Angela M Smith; Leigh C Coates; Niamh X Cawley; Y Peng Loh; Nigel P Birch
Journal:  Mol Cell Endocrinol       Date:  2006-12-16       Impact factor: 4.102

Review 4.  Prohormone and proneuropeptide processing. Recent progress and future challenges.

Authors:  M C Beinfeld
Journal:  Endocrine       Date:  1998-02       Impact factor: 3.633

5.  Processing of proaugurin is required to suppress proliferation of tumor cell lines.

Authors:  Akihiko Ozawa; Adam N Lick; Iris Lindberg
Journal:  Mol Endocrinol       Date:  2011-03-24

6.  Endoplasmic reticulum Ca2+ is important for the proteolytic processing and intracellular transport of proinsulin in the pancreatic beta-cell.

Authors:  P C Guest; E M Bailyes; J C Hutton
Journal:  Biochem J       Date:  1997-04-15       Impact factor: 3.857

Review 7.  Deorphanization of novel peptides and their receptors.

Authors:  Akihiko Ozawa; Iris Lindberg; Bryan Roth; Wesley K Kroeze
Journal:  AAPS J       Date:  2010-05-06       Impact factor: 4.009

8.  Synthetic small-molecule prohormone convertase 2 inhibitors.

Authors:  Dorota Kowalska; Jin Liu; Jon R Appel; Akihiko Ozawa; Adel Nefzi; Robert B Mackin; Richard A Houghten; Iris Lindberg
Journal:  Mol Pharmacol       Date:  2008-12-12       Impact factor: 4.436

9.  Differences in the autocatalytic cleavage of pro-PC2 and pro-PC3 can be attributed to sequences within the propeptide and Asp310 of pro-PC2.

Authors:  K Scougall; N A Taylor; J L Jermany; K Docherty; K I Shennan
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

10.  Biochemical and cell biological properties of the human prohormone convertase 1/3 Ser357Gly mutation: a PC1/3 hypermorph.

Authors:  Elias H Blanco; Juan R Peinado; Martín G Martín; Iris Lindberg
Journal:  Endocrinology       Date:  2014-06-16       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.